CTX-5861

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCTX-5861
Drug Alias NameCTX-5861
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsSignal-regulatory protein alpha inhibitorsMacrophages stimulants
TargetsSignal-regulatory protein alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCompass Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesCompass Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A